Published in J Clin Microbiol on July 01, 2006
The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med Microbiol Immunol (2008) 1.17
Use of saliva as a lubricant in anal sexual practices among homosexual men. J Acquir Immune Defic Syndr (2009) 1.13
Detection of Entamoeba histolytica DNA in the saliva of amoebic liver abscess patients who received prior treatment with metronidazole. J Health Popul Nutr (2008) 1.03
Monocytes as regulators of inflammation and HIV-related comorbidities during cART. J Immunol Res (2014) 0.98
Incidence of multiple Herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario. Virol J (2010) 0.93
Human herpesvirus replication and abnormal CD8+ T cell activation and low CD4+ T cell counts in antiretroviral-suppressed HIV-infected patients. PLoS One (2009) 0.90
Treatment-dependent loss of polyfunctional CD8+ T-cell responses in HIV-infected kidney transplant recipients is associated with herpesvirus reactivation. Am J Transplant (2009) 0.88
High seroprevalence of human herpesviruses in HIV-infected individuals attending primary healthcare facilities in rural South Africa. PLoS One (2014) 0.87
Primary gamma-herpesviral infection in Zambian children. BMC Infect Dis (2010) 0.87
Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2010) 0.87
Congenital and postnatal CMV and EBV acquisition in HIV-infected Zimbabwean infants. PLoS One (2014) 0.86
Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes. J Clin Virol (2007) 0.86
HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysis. Int J Cancer (2015) 0.86
Longitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIV. J Med Virol (2013) 0.85
Plausibility of HIV-1 Infection of Oral Mucosal Epithelial Cells. Adv Dent Res (2011) 0.85
Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1. Clin Oral Investig (2011) 0.84
Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts. Cancer Lett (2011) 0.83
Lipoteichoic acid (LTA) and lipopolysaccharides (LPS) from periodontal pathogenic bacteria facilitate oncogenic herpesvirus infection within primary oral cells. PLoS One (2014) 0.82
Heat-induced reactivation of HSV-1 in latent mice: upregulation in the TG of CD83 and other immune response genes and their LAT-ICP0 locus. Invest Ophthalmol Vis Sci (2009) 0.81
Epstein-Barr Virus MicroRNA Expression Increases Aggressiveness of Solid Malignancies. PLoS One (2015) 0.80
Human cytomegalovirus tropism for mucosal myeloid dendritic cells. Rev Med Virol (2014) 0.80
LACK OF ASSOCIATION BETWEEN HERPESVIRUS DETECTION IN SALIVA AND GINGIVITIS IN HIV‑INFECTED CHILDREN. Rev Inst Med Trop Sao Paulo (2015) 0.79
Emmprin and KSHV: new partners in viral cancer pathogenesis. Cancer Lett (2013) 0.78
Transcriptomic analysis of KSHV-infected primary oral fibroblasts: The role of interferon-induced genes in the latency of oncogenic virus. Oncotarget (2016) 0.78
Effects of long-term use of antiretroviral therapy on the prevalence of oral Epstein-Barr virus. J Oral Pathol Med (2011) 0.78
Detection of human cytomegalovirus in bronchoalveolar lavage fluid of lung transplant recipients reflects local virus replication and not contamination from the throat. J Clin Microbiol (2010) 0.78
Oral HHV-8 replication among women in Mombasa, Kenya. J Med Virol (2014) 0.77
Burning mouth syndrome due to herpes simplex virus type 1. BMJ Case Rep (2015) 0.75
Prevalence and risk factors for oral DNA tumor viruses in HIV-infected youth. J Med Virol (2016) 0.75
Virus and host-specific differences in oral human herpesvirus shedding kinetics among Ugandan women and children. Sci Rep (2017) 0.75
Oral shedding of Herpesviruses in HIV+ patients with varying degrees of immune status. AIDS (2017) 0.75
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med (1998) 53.26
Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet (1995) 10.63
Mucosal shedding of human herpesvirus 8 in men. N Engl J Med (2000) 6.59
Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis (2002) 5.09
Visualization of specific B and T lymphocyte interactions in the lymph node. Science (1998) 5.04
Methods for collecting saliva. Ann N Y Acad Sci (1993) 3.65
Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J Clin Microbiol (1999) 3.48
Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes (2004) 3.47
The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol (2002) 3.10
Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol (1999) 2.95
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology (1999) 2.49
Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J Virol (1999) 2.25
HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci (2005) 2.13
Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol (2000) 2.05
Detection of a second widespread strain of Epstein-Barr virus. Lancet (1989) 1.93
Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virology (2000) 1.93
Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J Infect Dis (1996) 1.85
Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis (1997) 1.84
Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDS (2005) 1.84
Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol (1997) 1.76
Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis (2002) 1.72
Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J Virol (2005) 1.71
Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol (2003) 1.70
AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr Opin Infect Dis (2006) 1.66
Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet (1990) 1.64
Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol (2003) 1.64
Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis (2004) 1.64
The germinal center: a crucible for lymphocyte selection. Semin Immunol (1996) 1.56
Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Engl J Med (1986) 1.49
Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes Infect (2000) 1.35
Kaposi's sarcoma: an update. J Surg Oncol (2004) 1.34
Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. J Med Virol (2002) 1.34
National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex Transm Dis (2004) 1.32
Epidemiology of genital herpes simplex virus infection in developed countries. Herpes (2004) 1.31
Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am J Pathol (2000) 1.29
Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain. Int J Cancer (2002) 1.27
Sensitive method for detection of human herpesviruses 6 and 7 in saliva collected in field studies. J Clin Microbiol (2000) 1.25
Utility of a multiplex PCR assay for detecting herpesvirus DNA in clinical samples. J Clin Microbiol (2002) 1.20
High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs. J Infect Dis (2005) 1.16
Herpes virus in an obstetric hospital. II: Asymptomatic virus excretion in staff members. Med J Aust (1980) 1.14
Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids. J Infect Dis (1998) 1.11
Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells. J Virol (2004) 1.11
Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity. J Antimicrob Chemother (2004) 1.08
Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus. Clin Infect Dis (1996) 1.05
Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J Clin Microbiol (1999) 1.05
Human herpesvirus 8 detection in nasal secretions and saliva. J Infect Dis (1998) 1.04
Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis (2003) 1.04
Quantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR. J Clin Microbiol (2000) 1.03
Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J Med Virol (1994) 1.02
Shedding of cytomegalovirus and herpesviruses 6, 7, and 8 in saliva of human immunodeficiency virus type 1-infected patients and healthy controls. Clin Infect Dis (1998) 1.02
Real-time PCR for quantification of human herpesvirus 6 DNA from lymph nodes and saliva. J Clin Microbiol (2002) 0.99
Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients. Clin Infect Dis (2001) 0.99
Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus. Commun Dis Rep CDR Rev (1996) 0.96
Prevalence of human herpesvirus-8 salivary shedding in HIV increases with CD4 count. J Dent Res (2004) 0.95
Detection of Kaposi's sarcoma-associated herpesvirus in oral and genital secretions of Zimbabwean women. J Infect Dis (2000) 0.94
HHV-8 infection: a model for reactivation and transmission. Rev Med Virol (2002) 0.93
Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment. J Clin Microbiol (2005) 0.93
Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study. Int J STD AIDS (2005) 0.93
AIDS and associated malignancies. Cell Res (2005) 0.91
Detection of Epstein-Barr virus in saliva by real-time PCR. Oral Microbiol Immunol (2004) 0.90
Detection of herpes simplex virus (HSV) in the saliva from 1,000 oral surgery outpatients by the polymerase chain reaction (PCR) and virus isolation. J Oral Pathol Med (1994) 0.89
Direct identification by PCR of EBV types and variants in clinical samples. J Med Virol (1997) 0.88
Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS (1998) 0.87
Human herpesvirus 8 DNA sequences in CD8+ T cells. J Infect Dis (1997) 0.87
Cytomegalovirus excretion in children attending day-care centers. Arch Med Res (2005) 0.85
Epstein-Barr virus (EBV) DNA in saliva and EBV serology of HIV-1-infected persons with and without hairy leukoplakia. J Infect (1995) 0.85
Seroprevalence of HSV-1 and HSV-2 in Barbados. Med Microbiol Immunol (2005) 0.83
Infectious mononucleosis: observations on transmission. Yale J Biol Med (1983) 0.82
Human herpes virus-6 seroprevalence and leukaemias: a case-control study. GIMEMA (Gruppo Italiano Malattie Ematologiche dell' Adulto). Br J Cancer (1999) 0.81
Multiple herpesviruses in saliva of HIV-infected individuals. J Am Dent Assoc (1994) 0.80
The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures. J Am Dent Assoc (2004) 0.79
Presence of human herpes virus-8 in saliva and non-lesional oral mucosa in HIV-infected and oncologic immunocompromised patients. Oral Microbiol Immunol (2004) 0.79
Seroprevalence of cytomegalovirus infection among children and females in Ankara, Turkey, 1995. Pediatr Int (1999) 0.78
Relationship of cytomegalovirus to salivary gland dysfunction in HIV-infected patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1997) 0.78
Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet (2005) 10.11
Genome sequence of Streptococcus mutans UA159, a cariogenic dental pathogen. Proc Natl Acad Sci U S A (2002) 8.25
Neuropathologic substrate of mild cognitive impairment. Arch Neurol (2006) 6.26
Functional profiling of a human cytomegalovirus genome. Proc Natl Acad Sci U S A (2003) 5.21
Tooth loss, dementia and neuropathology in the Nun study. J Am Dent Assoc (2007) 3.29
Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol (2007) 2.70
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. Nat Genet (2003) 2.67
Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc (2006) 2.48
Modeling the association between 43 different clinical and pathological variables and the severity of cognitive impairment in a large autopsy cohort of elderly persons. Brain Pathol (2008) 2.44
Predicting risk of malignancy in adnexal masses. Obstet Gynecol (2010) 2.31
Comparative analysis of the genomes of the temperate bacteriophages phi 11, phi 12 and phi 13 of Staphylococcus aureus 8325. Gene (2002) 2.30
Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy. Sci Transl Med (2012) 2.27
Hippocampal sclerosis in advanced age: clinical and pathological features. Brain (2011) 2.16
Patterns of colorectal cancer incidence, risk factors, and screening in Kentucky. South Med J (2004) 1.94
Bone remodeling biomarkers of periodontal disease in saliva. J Periodontol (2008) 1.88
Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling. J Clin Invest (2012) 1.87
Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences. N Engl J Med (2005) 1.85
Introns and splicing elements of five diverse fungi. Eukaryot Cell (2004) 1.83
Selecting treatment for patients with malignant epidural spinal cord compression-does age matter?: results from a randomized clinical trial. Spine (Phila Pa 1976) (2009) 1.79
Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography. Obstet Gynecol (2013) 1.77
Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation. Gynecol Oncol (2003) 1.75
Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J Neurol (2009) 1.73
Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol (2011) 1.72
Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc Natl Acad Sci U S A (2012) 1.71
An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus. J Infect Dis (2013) 1.67
miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res Bull (2009) 1.66
Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. J Neuropathol Exp Neurol (2009) 1.66
Lifelong bilingualism maintains neural efficiency for cognitive control in aging. J Neurosci (2013) 1.62
Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment. Blood (2003) 1.62
Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol (2011) 1.62
Delayed fingolimod-associated asystole. Mult Scler (2011) 1.61
Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer (2007) 1.61
The search for meaning-Symptoms and transvaginal sonography screening for ovarian cancer: predicting malignancy. Cancer (2009) 1.59
Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis. Blood (2010) 1.56
The smallest capsid protein mediates binding of the essential tegument protein pp150 to stabilize DNA-containing capsids in human cytomegalovirus. PLoS Pathog (2013) 1.54
University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr Alzheimer Res (2012) 1.52
Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J Virol (2007) 1.52
Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol (2005) 1.49
Silencing of elongation factor-2 kinase potentiates the effect of 2-deoxy-D-glucose against human glioma cells through blunting of autophagy. Cancer Res (2009) 1.42
Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol (2013) 1.41
Blood pressure response to transcendental meditation: a meta-analysis. Am J Hypertens (2008) 1.39
Reduced risk of incident AD with elective statin use in a clinical trial cohort. Curr Alzheimer Res (2008) 1.38
Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis. Am J Pathol (2005) 1.37
Shared random effects analysis of multi-state Markov models: application to a longitudinal study of transitions to dementia. Stat Med (2007) 1.36
Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy. Gynecol Oncol (2002) 1.31
Phenotypic characterization of clonal and nonclonal Pseudomonas aeruginosa strains isolated from lungs of adults with cystic fibrosis. J Clin Microbiol (2007) 1.29
Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J Virol (2007) 1.29
Novel avian-origin human influenza A(H7N9) can be transmitted between ferrets via respiratory droplets. J Infect Dis (2013) 1.28
Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol (2004) 1.27
Lab-on-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis. Ann N Y Acad Sci (2007) 1.26
Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. J Virol (2008) 1.25
MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells. J Biol Chem (2010) 1.23
The HIV Dementia Scale: predictive power in mild dementia and HAART. J Neurol Sci (2007) 1.23
Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol (2011) 1.22
Persistence and pathogenesis of the neurotropic polyomavirus JC. Ann Neurol (2015) 1.21
miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor. Brain Res (2010) 1.18
Quorum-sensing regulation of adhesion in Serratia marcescens MG1 is surface dependent. J Bacteriol (2007) 1.18
MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling. Nat Commun (2013) 1.16
Nonmuscle myosin IIA facilitates vesicle trafficking for MG53-mediated cell membrane repair. FASEB J (2012) 1.16
Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor. PLoS Pathog (2010) 1.16
Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia. J Neurovirol (2004) 1.15
Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment. Neurosci Lett (2008) 1.15
Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis. J Med Microbiol (2008) 1.14
ALS syndrome in patients with HIV-1 infection. J Neurol Sci (2005) 1.14
Two gamma interferon-activated site-like elements in the human cytomegalovirus major immediate-early promoter/enhancer are important for viral replication. J Virol (2005) 1.13
Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain (2013) 1.13
Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in δ-Sarcoglycan-deficient hamsters. Mol Ther (2012) 1.13
An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J Pathol (2005) 1.12
Novel protein ADTRP regulates TFPI expression and function in human endothelial cells in normal conditions and in response to androgen. Blood (2011) 1.12
Impact of cleaning regimens in silver-impregnated and hydrogen peroxide lens cases. Eye Contact Lens (2011) 1.09
Stroke in HIV infection and AIDS. Expert Rev Cardiovasc Ther (2009) 1.09
A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo. Virol J (2010) 1.09
Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort. Neurodegener Dis (2010) 1.08
Herpesvirus BACs: past, present, and future. J Biomed Biotechnol (2010) 1.08
ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology. Acta Neuropathol (2014) 1.07
1 alpha,25-Dihydroxyvitamin D3 inhibits pro-inflammatory cytokine and chemokine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa. Immunol Cell Biol (2002) 1.07
A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system. J Virol Methods (2008) 1.06
Update on progressive multifocal leukoencephalopathy. Curr Neurol Neurosci Rep (2012) 1.06
JC virus detection in bodily fluids: clues to transmission. Clin Infect Dis (2006) 1.06
Association between male gender and cortical Lewy body pathology in large autopsy series. J Neurol (2010) 1.06
High nrDNA ITS polymorphism in the ancient extant seed plant Cycas: incomplete concerted evolution and the origin of pseudogenes. Mol Phylogenet Evol (2009) 1.05
Focal cerebral ischemia in the TNFalpha-transgenic rat. J Neuroinflammation (2008) 1.04
Patterns of salivary analytes provide diagnostic capacity for distinguishing chronic adult periodontitis from health. J Clin Immunol (2012) 1.03
Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition. J Alzheimers Dis (2011) 1.03
Human mesenchymal stem cell transplantation protects against cerebral ischemic injury and upregulates interleukin-10 expression in Macacafascicularis. Brain Res (2010) 1.03
Mass lesions of the brain in AIDS: the dilemmas of distinguishing toxoplasmosis from primary CNS lymphoma. AJNR Am J Neuroradiol (2003) 1.02
Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus. J Virol (2004) 1.02
Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model. FASEB J (2006) 1.02
Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. Leuk Lymphoma (2012) 1.02
Activation of platelet alphaIIbbeta3 by an exogenous peptide corresponding to the transmembrane domain of alphaIIb. J Biol Chem (2006) 1.02
A multi-mode shock tube for investigation of blast-induced traumatic brain injury. J Neurotrauma (2011) 1.02
Vitamin E and all-cause mortality: a meta-analysis. Curr Aging Sci (2011) 1.01
Mild cognitive impairment: statistical models of transition using longitudinal clinical data. Int J Alzheimers Dis (2012) 1.01
Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach. Proteomics (2005) 1.01